More importantly, there was an increased infiltration of both CD4 and CD8 T cells in the combination or anti PD-1 therapy groups, due to activation and expansion of the tumor-resident T cells, as seen by the increased granzyme and interferon gamma production. The gene discussed is CD8A; the disease is neoplasm.